Spectrophotometric Method for Determination of Primaquine in Pharmaceutical Formulations via Derivatization with 1,2-Naphthoquinone-4-Sulfonate

Research Article

Austin J Anal Pharm Chem. 2014;1(4): 1019.

Spectrophotometric Method for Determination of Primaquine in Pharmaceutical Formulations via Derivatization with 1,2-Naphthoquinone-4-Sulfonate

Aida Makram Nouralla Altigani, Abdalla Ahmed Elbashir*

University of Khartoum, Faculty of Science, Chemistry Department, Sudan

*Corresponding author: :Abdalla Ahmed Elbashir, University of Khartoum, Faculty of Science, Chemistry Department, Sudan.

Received: October 10, 2014; Accepted: October 23, 2014; Published: October 25, 2014

Abstract

A rapid, simple and sensitive method for the determination of primaquine (PQ) using sodium 1,2-naphthoquinone-4-sulfonate (NQS) has been developed. The method is based on the formation of a brown color adduct from the reaction between PQ and NQS. The nucleophilic substitution reaction proceeds quantitatively at pH 10 buffer solution with absorption maximum at 485 nm. The calibration curve is linear over the range 10-60μg/mL and describes by the regression equation A? 0.005X+ 0.055C with a regression coefficient 0.9998. The limit of detection and quantity are 3.2 μg/mL and 9.9 μg/ mL respectively. The method is simple and can be applied for determination of PQ in pharmaceutical formulation in quality control laboratories.

Keywords: Spectrophotometric; Primaquine; Pharmaceutical formulation; Sodium1; 2-naphthoquinone-4-sulfonic (NQS)

Introduction

The drug primaquine (PQ) chemically known as diphosphate 8-[(4-amino-1-methylbutyl) amino]-6-methoxyquinoline is still the drug of choice for the eradication of the exoerythrocytic liver forms of Plasmodium vivax and Plasmodium ovale for the prevention of relapse of malaria [1]. The clinical use of PQ as a causal prophylactic and the rapeutic agent is, however, curtailed by its toxic side effect, especially for patients with glucose-6-phosphate dehydrogenize deficiency [2].

Several methods for the determination of PQ have been reported. This includes a reversed-phase HPLC method for the separation and identification of the oxidation products of PQ [3] as well as determination of PQ and its metabolite (carboxyprimaquine) in plasma and blood cell [4] and in calf plasma by LC-EC detection [5]. Other methods such as chemical sensors [6], Capillary electrophoresis [7-9] Spectrophotometric [10-14] and spectrofluorimetry [15] have also been proposed. The British Pharmacopoeia method [16] involves the dissolution of the sample in anhydrous acetic acid with gentle heating. The cooled, sample is titrated against perchloric acid, and the end point is determined potentiometrically.

NQS has been used as a color-developing reagent in spectrophotometric determination of pharmaceutical amines [17-28]. The applications of NQS for determination of NQS of pharmaceutical bearing amine group have recently been reviewed by Elbashir et al., [26]. The reaction between PQ and NQS has not investigated yet, therefore, the present study was devoted to investigate the reaction between NQS and PQ, and use this color reaction in the development of simple, rapid spectrophotometric method for determination of PQ in pharmaceutical formulation.

Experimental

Apparatus

Absorbance was carried out by using a spectrophotometer model shimadzu 1800. With quartz cells of 1cm optical path length. pH meter was used for pH measurements.

Material and Reagent

All chemicals used were of analytical reagent grade. 1,2 naphthoquinone-4-sulfonate (NQS) and primaquine diphosphate standard (PQ) were obtained from (Aldrich Chemical Co., St. Louis, USA). Commercial primaquine diphosphate pharmaceutical preparations in the form of tablets, (claimed to contain 7.5 mg active ingredient) were purchased from a local drug-store. Doubly distilled water was used to prepare all solutions.

Preparation of standard and sample solution

Stock standard solution of PQ (200 μg/ mL)

An accurately 0.02 g of PQ standard was dissolved in distilled water and transferred in 100 mL volumetric flask diluted to mark. The solution was further diluted to obtain working solution.

Sample Solution

Four tablets (PQ 15 mg / tablet) were weighted and finely powdered. A portion of the powder equivalent to 0.09 g of the drug was dissolved in distilled water and transferred into 50 mL volumetric flask the solution was completed to mark, shaken well filtered and then analyzed by following procedure.

NQS (0.4%, w/v)

Was prepared by dissolving 0.4 g in 100 mL volumetric flask and complete the volume with distilled water. The solution was freshly prepared.

Procedure

A 2.0 mL of 200 μg / mL PQ was transferred in 10 mL volumetric flask, 2.0 mL of NQS was added and followed by 1.5 mL of buffer solution pH 10, the flask was completed to volume with distilled water and the absorbance was measured at 485 nm against blank.

Job's method

The Job's method of continuous variation [29] was employed master equimolar (1x10-3 M). Aqueous solution of PQ and NQS were prepared. Series of master solution of PQ and NQS were made up comprising different complementary proportions (1:9,...9:1, inclusive) in 10 mL volumetric flask containing 1.5 mL of buffer solution pH=10.

Results and Discussion

Absorption spectra

The absorbance spectrum of PQ were carried out against water it was found that PQ exhibits maximum absorption peak λ max at 360 nm (Figure 1a). The reaction between PQ and NQS was performed and the absorption spectrum of product was recorded against blank (Figure 1c) it was found that the product is brown colored exhibiting λ max at 485 nm and the λ max of NQS at 362 nm (Figure 1b).